Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Excellent Medical Technology Group Co EBITDA Margin %?
Excellent Medical Technology Group CoBJSE:920050 17 EBITDA Margin % is 10.90% as of Jun. 2026, which is 40% below its 10-year median of 18.29. GuruFocus rates BJSE:920050 with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Excellent Medical Technology Group Co ranks better than 52.83% on this metric.
Excellent Medical Technology Group Co (BJSE:920050) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Excellent Medical Technology Group Co EBITDA Margin % Related Terms
Excellent Medical Technology Group Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Excellent Medical Technology Group Co EBITDA Margin % Chart
Excellent Medical Technology Group Co Annual Data
Trend
Dec21
Dec22
Dec23
Dec24
Dec25
EBITDA Margin %
25.22
17.79
19.17
18.29
14.32
Excellent Medical Technology Group Co Quarterly Data
BJSE:920050 vs ISRG, BDX, RMD: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Excellent Medical Technology Group Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Excellent Medical Technology Group Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Excellent Medical Technology Group Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Excellent Medical Technology Group Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Excellent Medical Technology Group Co (BJSE:920050) has a EBITDA Margin % of 10.90% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Excellent Medical Technology Group Co and its competitors. This is 40% below median its historical median of 18.29. Over the past decade, Excellent Medical Technology Group Co's EBITDA Margin % has ranged from 9.48 to 25.22. According to the industry distribution chart, Excellent Medical Technology Group Co ranks #384 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 47.2%.
Is Excellent Medical Technology Group Co's EBITDA Margin % too high?
Excellent Medical Technology Group Co's current EBITDA Margin % of 10.90% is 40% below median its 10-year median of 18.29. Over the past 10 years, this metric has ranged from a low of 9.48 to a high of 25.22. The Medical Devices & Instruments industry median EBITDA Margin % is 7.98. Excellent Medical Technology Group Co's value of 10.90% is 36.6% above this industry median. Based on the distribution chart, Excellent Medical Technology Group Co ranks #384 out of 814 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Excellent Medical Technology Group Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Excellent Medical Technology Group Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Excellent Medical Technology Group Co ranks #384 out of 814 companies for EBITDA Margin %. This puts Excellent Medical Technology Group Co in the upper half of its industry. The industry median EBITDA Margin % is 7.98. Excellent Medical Technology Group Co's value of 10.90% is 36.6% above this benchmark. Historically, Excellent Medical Technology Group Co's own EBITDA Margin % has ranged from 9.48 to 25.22 over the past decade. While the company's 10-year median is 18.29 vs. the industry median of 7.98, Excellent Medical Technology Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.98, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Excellent Medical Technology Group Co's current EBITDA Margin % of 10.90% is 36.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Excellent Medical Technology Group Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Excellent Medical Technology Group Co's current EBITDA Margin % is 10.90%, which is 40% below median its own 10-year median of 18.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Excellent Medical Technology Group Co stock overvalued right now?
Excellent Medical Technology Group Co (BJSE:920050) has a current EBITDA Margin % of 10.90%. The current EBITDA Margin % is 10.90%, which is 40% below median its 10-year median of 18.29 and 36.6% above the Medical Devices & Instruments industry median of 7.98. Excellent Medical Technology Group Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Excellent Medical Technology Group Co (BJSE:920050), the current EBITDA Margin % is 10.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Excellent Medical Technology Group Co Ltd is engaged in the research, development, production, and sale of disposable medical consumables. Its products are used in professional rehabilitation care and medical protection applications.
17GF Score
Get the complete analysis for BJSE:920050
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920050 has been successfully added to your 
